| | Identification | Back Directory |  | [Name] 
 ST072042
 |  | [CAS] 
 88349-90-0
 |  | [Synonyms] 
 A2793
 ST072042
 ethyl [(5-chloroquinolin-8-yl)oxy]acetate
 ethyl 2-(5-chloroquinolin-8-yl)oxyacetate
 ethyl 2-[(5-chloro-8-quinolyl)oxy]acetate
 ethyl 2-(5-chloroquinolin-8-yl)oxyethanoate
 2-[(5-chloro-8-quinolyl)oxy]acetic acid ethyl ester
 Acetic acid, 2-[(5-chloro-8-quinolinyl)oxy]-, ethyl ester
 |  | [Molecular Formula] 
 C13H12ClNO3
 |  | [MDL Number] 
 MFCD04275530
 |  | [MOL File] 
 88349-90-0.mol
 |  | [Molecular Weight] 
 265.69
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 393.4±27.0 °C(Predicted)
 |  | [density ] 
 1.291±0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 Store at -20°C
 |  | [solubility ] 
 DMSO: 100 mg/mL (376.38 mM)
 |  | [form ] 
 Solid
 |  | [pka] 
 1.97±0.29(Predicted)
 |  | [color ] 
 White to off-white
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 A2793 is an efficient dual TWIK-related acid-sensitive K+ channel (TASK)-1/TRESK inhibitor, with an IC50 of 6.8 μM for mTRESK.  A2764 is more selective for TRESK, and it only moderately influences TREK-1 and TALK-1[1].
 |  | [Biological Activity] 
 A2793 (Ethyl [(5-Chloroquinolin-8-yl)oxy]acetate) is a TWIK-related spinal cord potassium channel (TRESK, K2P18, KCNK18) and TASK-1 (KCNK3) with IC50 of 6.8 μM for mouse TRESK .
 |  | [in vitro] 
 
   A2793 (100 μM) inhibits the unstimulated channel by 43.0±8.9% (n=5) while after ionomycin activation the reduction of the TRESK current is 85.5±2.9% (n=5). It inhibits TASK-1 (100 μM, 53.4±13,5%, n=5), while A2764 is more selective for TRESK, it only moderately influences TREK-1 and TALK-1.
 A2793 may be considered as a tool to discriminate between the resting and activated channels in heterologous expression systems, and to block TRESK activated by calcineurin in the native cells which do not express TASK-1.
 
     |  | [target] 
 
 | Target | Value |  | mTRESK (Cell-free assay)
 | 6.8 μM | 
 |  | [References] 
 [1] Miklós Lengyel, et al. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K 2P 18.1) Background Potassium Channel. Mol Pharmacol. 2019 Jun;95(6):652-660. DOI:10.1124/mol.118.115626
 | 
 | 
                    
                        
                            | Company Name: | InvivoChem |  
                            | Tel: | 13549236410 |  
                            | Website: | https://www.invivochem.cn/ |  |